Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study.

导出 LinkOut

翻译打印收藏纠错

作者： Andrew J,Cutler ^[1] ; Scott H,Kollins ^[2] ; Matthew N,Brams ^[3] ; Meg,Corliss ^[4] ; Charles,Oh ^[5] ; Rene,Braeckman ^[6] ; Ann C,Childress ^[6]

作者单位： State University of New York (SUNY) Upstate Medical University, Syracuse, NY, United States. ^[1] Neuroscience Education Institute, Lakewood Ranch, FL, United States. ^[2] Duke University School of Medicine, Durham, NC, United States. ^[3] Akili Interactive, Inc., Boston, MA, United States. ^[4] Bayou City Research, Houston, TX, United States. ^[5] Corium LLC, Boston, MA, United States. ^[6] Zevra Therapeutics Inc., Celebration, FL, United States. ^[7] Center for Psychiatry and Behavioral Medicine, Las Vegas, NV, United States. ^[8]

关键词 ADHD ADHD-RS-5 Azstarys Conners 3-P SDX/d-MPH dose optimization

DOI 10.3389/fpsyt.2024.1310483

PMID 38566957

发布时间 2024-04-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in psychiatry

2024年15卷

1310483页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study.

Frontiers in psychiatry

相似文献

Frontiers in psychiatry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study.

Frontiers in psychiatry

相似文献

Frontiers in psychiatry

相关期刊

检索历史清除